Vertex's $350,000 pills cause a stir in Canada Add to ...

SHARE

Replay
BNN Video |
Show Description
Robyn Karnauskas, Biotechnology Analyst, Deutsche Bank breaks down the numbers for the growing number of astronomical treatments.

More from this section

Most Popular

Editor's Picks

Globe Shows »

Careers
Put your best foot forward with our expert advice